NTRK2 and central nervous system cancer: While recent work independently highlights the evolving importance of aberrant splicing in cancer1–3, simultaneous discoveries have implicated novel NTRK2 fusions in various glioma subtypes4–10, yet little is known about endogenous NTRK2 splicing in human brain or its potential role in brain tumor biology.